Zimmer Biomet
765 hedge funds and large institutions have $21.5B invested in Zimmer Biomet in 2016 Q2 according to their latest regulatory filings, with 78 funds opening new positions, 269 increasing their positions, 246 reducing their positions, and 51 closing their positions.
53% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 51
18% more funds holding in top 10
Funds holding in top 10: 17 → 20 (+3)
15% more capital invested
Capital invested by funds: $18.7B → $21.5B (+$2.83B)
3% more funds holding
Funds holding: 746 → 765 (+19)
9% more repeat investments, than reductions
Existing positions increased: 269 | Existing positions reduced: 246
3% less call options, than puts
Call options by funds: $46.9M | Put options by funds: $48.2M
1.72% less ownership
Funds ownership: 94.31% → 92.59% (-1.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$300M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$158M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$156M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$152M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$151M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
-$520M |
| 2 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$439M |
| 3 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$428M |
| 4 |
Goldman Sachs
New York
|
-$398M |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
-$80.7M |
ZBH Hedge Fund Activity: Q2 2016 in Review
765 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2016, worth a combined $21.5B — up 15% from $18.7B a quarter earlier.
Buyers outnumbered sellers: 78 funds opened new ZBH positions and 51 closed out — a net gain of 27 holders — while 269 added to existing stakes and 246 trimmed.
The largest buyer was Winslow Capital Management, opening a new position worth an estimated $300M. The largest seller was Royal London Asset Management, cutting an estimated $520M.
- 765 institutional investors held Zimmer Biomet (ZBH) as of Q2 2016, up from 746 in Q1 2016.
- Funds reported $21.5B of Zimmer Biomet stock for Q2 2016, up 15% quarter-over-quarter.
- 78 funds opened new Zimmer Biomet positions in Q2 2016 and 51 closed out, a net change of +27 holders.
- The largest Zimmer Biomet buyer in Q2 2016 was Winslow Capital Management, an estimated $300M added.
- The largest Zimmer Biomet seller in Q2 2016 was Royal London Asset Management, an estimated $520M sold.
Based on aggregated 13F filings for Q2 2016.